SAO PAULO (Reuters) – São Paulo’s Butantan Institute biomedical center on Thursday received 1 million doses of a Chinese COVID-19 vaccine developed by Sinovac Biotech Ltd that is undergoing late-stage testing by the institute at 16 locations in Brazil.
The consignment of CoronaVac vaccine will be packaged and labeled at Butantan’s facilities pending regulatory approval. Butantan said it expected Sinovac to publish efficacy results from its vaccine trials by Dec. 15.
Via Reuters